日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CRISPR-Cas9-mediated therapeutics: Current clinical trials and therapy approval landscape to treat human diseases

CRISPR-Cas9介导的疗法：当前治疗人类疾病的临床试验和疗法审批情况

期刊:Molecular Therapy-Nucleic Acids
影响因子:6.1
doi:10.1016/j.omtn.2026.102859
Chakraborty, Chiranjib; Bhattacharya, Manojit; Das, Arpita; Agoramoorthy, Govindasamy; Lee, Sang-Soo
发表日期：2026
文献求助 收藏

Psychosocial impact of living with an indwelling pleural catheter in patients with malignant pleural effusions: a thematic analysis

恶性胸腔积液患者留置胸膜导管的心理社会影响：主题分析

期刊:Bmj Open Respiratory Research
影响因子:3.4
doi:10.1136/bmjresp-2024-002993
Zhang, Junyi; Liang, Janeth; Agoramoorthy, Laletha; Montalvo, Shanik; Kadwani, Owais; Radcliffe, Gillian; Sivakumar, Parthipan
发表日期：2025
文献求助 收藏

DENV-1 and DENV-2 more prevalent in dengue-dominated Southeast Asia as a natural geographic cluster

登革病毒1型和2型在登革热流行的东南亚地区更为普遍，这反映了该地区自然形成的地理聚集性。

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000003160
Chakraborty, Chiranjib; Bhattacharya, Manojit; Islam, Md Aminul; Agoramoorthy, Govindasamy
微生物学
登革热
发表日期：2025
文献求助 收藏

Evidence on the existence of sublineages of the current human monkeypox virus: time for in depth study

关于当前人类猴痘病毒亚系存在的证据：是时候进行深入研究了

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000085
Chakraborty, Chiranjib; Bhattacharya, Manojit; Dhama, Kuldeep; Agoramoorthy, Govindasamy
微生物学
猴痘
发表日期：2024
文献求助 收藏

Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets, and Structure-Based Druggability

SARS-CoV-2单链RNA基因组中非结构蛋白编码基因组区域的结构图谱：一种用于识别可成药基因组、配体结合口袋和基于结构的成药性的结构基因组学方法

期刊:Molecular Biotechnology
影响因子:2.5
doi:10.1007/s12033-022-00605-x
Chakraborty, Chiranjib; Bhattacharya, Manojit; Sharma, Ashish Ranjan; Chatterjee, Srijan; Agoramoorthy, Govindasamy; Lee, Sang-Soo
SARS-CoV-2
发表日期：2024
文献求助 收藏

Artificial intelligence-enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period

人工智能赋能的临床试验或许能更快地开展临床试验，并有助于应对未来的流行病：从新冠疫情期间汲取的经验教训

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000088
Chakraborty, Chiranjib; Bhattacharya, Manojit; Dhama, Kuldeep; Agoramoorthy, Govindasamy
微生物学
新冠
发表日期：2023
文献求助 收藏

ChatGPT indicates the path and initiates the research to open up the black box of artificial intelligence

ChatGPT 指明了方向，并启动了揭开人工智能黑匣子的研究。

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000701
Chakraborty, Chiranjib; Bhattacharya, Manojit; Islam, Md Aminul; Agoramoorthy, Govindasamy
发表日期：2023
文献求助 收藏

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants

SARS-CoV-2 Omicron (B.1.1.529) 变体及其亚变体中 D614G 突变的自然选择

期刊:Molecular Therapy-Nucleic Acids
影响因子:6.1
doi:10.1016/j.omtn.2023.01.013
Chakraborty, Chiranjib; Saha, Abinit; Bhattacharya, Manojit; Dhama, Kuldeep; Agoramoorthy, Govindasamy
SARS-CoV-2
发表日期：2023
文献求助 收藏

A Paradigm Shift in the Combination Changes of SARS-CoV-2 Variants and Increased Spread of Delta Variant (B.1.617.2) across the World

SARS-CoV-2 变异株组合方式的范式转变以及 Delta 变异株 (B.1.617.2) 在全球范围内的传播加剧

期刊:Aging and Disease
影响因子:6.9
doi:10.14336/AD.2021.1117
Chakraborty, Chiranjib; Sharma, Ashish Ranjan; Bhattacharya, Manojit; Agoramoorthy, Govindasamy; Lee, Sang-Soo
SARS-CoV-2
发表日期：2022
文献求助 收藏

A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs

对新出现的 Omicron (B.1.1.529) 变体的突变图谱进行全面分析，并将突变与 VOC 和 VOI 进行比较。

期刊:Geroscience
影响因子:5.4
doi:10.1007/s11357-022-00631-2
Chakraborty, Chiranjib; Bhattacharya, Manojit; Sharma, Ashish Ranjan; Dhama, Kuldeep; Agoramoorthy, Govindasamy
发表日期：2022
文献求助 收藏